State Street’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$211M Buy
6,372,753
+287,752
+5% +$9.51M 0.01% 875
2025
Q1
$245M Sell
6,085,001
-82,339
-1% -$3.31M 0.01% 785
2024
Q4
$290M Sell
6,167,340
-290,984
-5% -$13.7M 0.01% 733
2024
Q3
$341M Sell
6,458,324
-90,212
-1% -$4.76M 0.01% 657
2024
Q2
$355M Buy
6,548,536
+2,028,178
+45% +$110M 0.02% 602
2024
Q1
$317M Sell
4,520,358
-1,373,000
-23% -$96.3M 0.01% 660
2023
Q4
$492M Buy
5,893,358
+618,872
+12% +$51.7M 0.02% 516
2023
Q3
$155M Buy
5,274,486
+182,906
+4% +$5.39M 0.01% 905
2023
Q2
$166M Buy
5,091,580
+337,680
+7% +$11M 0.01% 891
2023
Q1
$167M Sell
4,753,900
-291,014
-6% -$10.2M 0.01% 862
2022
Q4
$231M Buy
5,044,914
+789,789
+19% +$36.2M 0.01% 695
2022
Q3
$206M Sell
4,255,125
-249,101
-6% -$12.1M 0.01% 721
2022
Q2
$177M Buy
4,504,226
+307,394
+7% +$12.1M 0.01% 803
2022
Q1
$154M Buy
4,196,832
+211,605
+5% +$7.79M 0.01% 1002
2021
Q4
$182M Sell
3,985,227
-325,061
-8% -$14.8M 0.01% 915
2021
Q3
$154M Buy
4,310,288
+59,502
+1% +$2.13M 0.01% 982
2021
Q2
$84.1M Buy
4,250,786
+108,816
+3% +$2.15M ﹤0.01% 1436
2021
Q1
$96.3M Sell
4,141,970
-498,953
-11% -$11.6M 0.01% 1263
2020
Q4
$96.4M Buy
4,640,923
+860,663
+23% +$17.9M 0.01% 1173
2020
Q3
$81.8M Buy
3,780,260
+739,228
+24% +$16M 0.01% 1106
2020
Q2
$71.7M Buy
3,041,032
+355,470
+13% +$8.38M 0.01% 1194
2020
Q1
$31.7M Buy
2,685,562
+145,796
+6% +$1.72M ﹤0.01% 1545
2019
Q4
$26.9M Buy
2,539,766
+218,887
+9% +$2.32M ﹤0.01% 1930
2019
Q3
$26.4M Sell
2,320,879
-95,635
-4% -$1.09M ﹤0.01% 1879
2019
Q2
$27.2M Buy
2,416,514
+374,437
+18% +$4.21M ﹤0.01% 1898
2019
Q1
$16.5M Buy
2,042,077
+126,115
+7% +$1.02M ﹤0.01% 2168
2018
Q4
$12.1M Sell
1,915,962
-85,600
-4% -$541K ﹤0.01% 2327
2018
Q3
$19.7M Sell
2,001,562
-43,739
-2% -$431K ﹤0.01% 2190
2018
Q2
$17M Sell
2,045,301
-316,311
-13% -$2.63M ﹤0.01% 2241
2018
Q1
$17M Sell
2,361,612
-354,360
-13% -$2.55M ﹤0.01% 2163
2017
Q4
$22.1M Buy
2,715,972
+880,457
+48% +$7.18M ﹤0.01% 1980
2017
Q3
$26.6M Buy
1,835,515
+161,180
+10% +$2.34M ﹤0.01% 1819
2017
Q2
$20.3M Buy
1,674,335
+741,909
+80% +$8.98M ﹤0.01% 1969
2017
Q1
$12M Buy
932,426
+34,678
+4% +$446K ﹤0.01% 2268
2016
Q4
$10.9M Sell
897,748
-75,452
-8% -$917K ﹤0.01% 2290
2016
Q3
$8.94M Buy
973,200
+349,954
+56% +$3.21M ﹤0.01% 2245
2016
Q2
$5.91M Buy
623,246
+77,786
+14% +$738K ﹤0.01% 2499
2016
Q1
$3.85M Sell
545,460
-255,751
-32% -$1.8M ﹤0.01% 2687
2015
Q4
$8.38M Buy
801,211
+250,173
+45% +$2.62M ﹤0.01% 2290
2015
Q3
$3.69M Buy
551,038
+1,423
+0.3% +$9.53K ﹤0.01% 2667
2015
Q2
$3.69M Buy
549,615
+14,282
+3% +$96K ﹤0.01% 2795
2015
Q1
$3.63M Buy
535,333
+26,166
+5% +$177K ﹤0.01% 2744
2014
Q4
$4.08M Buy
509,167
+5,677
+1% +$45.5K ﹤0.01% 2675
2014
Q3
$1.78M Buy
503,490
+10,122
+2% +$35.7K ﹤0.01% 3067
2014
Q2
$2.36M Buy
493,368
+4,194
+0.9% +$20.1K ﹤0.01% 2986
2014
Q1
$4.65M Buy
489,174
+76,964
+19% +$731K ﹤0.01% 2606
2013
Q4
$2.68M Buy
412,210
+34,523
+9% +$224K ﹤0.01% 2929
2013
Q3
$2.87M Buy
377,687
+88,953
+31% +$676K ﹤0.01% 2862
2013
Q2
$3.34M Buy
+288,734
New +$3.34M ﹤0.01% 2688